...
search icon
sldb-img

Solid Biosciences LLC Share Price

SLDB
NSQ
$6.6
-$0.26
(-3.79%)
1D
Industry: Biotechnology Sector: Health Care

Solid Biosciences LLC Analyst Forecast

Solid Biosciences LLC Share Price Chart

Solid Biosciences LLC Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$534.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
866.43K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.69
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.41 L
$7.37 H
$6.6

About Solid Biosciences LLC, Common Stock

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts. more

Industry: BiotechnologySector: Health Care

Solid Biosciences LLC Stock Returns

Time FrameSLDBSectorS&P500
1-Week Return20.66%1.64%-0.4%
1-Month Return11.86%2.13%0.14%
3-Month Return19.57%8.39%2.61%
6-Month Return-2.37%16.16%8.7%
1-Year Return120%9.86%13%
3-Year Return-10.2%17.8%72.1%
5-Year Return-93.53%33.74%79.31%
10-Year Return-98.05%135.48%268.2%

Solid Biosciences LLC Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue3.33M13.62M8.09M--[{"date":"2020-12-31","value":24.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":59.43,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue3.92M2.96M2.41M2.58M2.46M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":75.57,"profit":true},{"date":"2022-12-31","value":61.4,"profit":true},{"date":"2023-12-31","value":65.81,"profit":true},{"date":"2024-12-31","value":62.6,"profit":true}]
Gross Profit(3.92M)13.62M8.09M(2.58M)(2.46M)[{"date":"2020-12-31","value":-28.8,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":59.43,"profit":true},{"date":"2023-12-31","value":-18.95,"profit":false},{"date":"2024-12-31","value":-18.02,"profit":false}]
Gross Margin(117.60%)100.00%100.00%--[{"date":"2020-12-31","value":-117.6,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses82.54M85.87M114.55M101.73M127.27M[{"date":"2020-12-31","value":64.85,"profit":true},{"date":"2021-12-31","value":67.47,"profit":true},{"date":"2022-12-31","value":90,"profit":true},{"date":"2023-12-31","value":79.93,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(86.46M)(72.25M)(106.45M)(104.31M)(129.73M)[{"date":"2020-12-31","value":-8646200000,"profit":false},{"date":"2021-12-31","value":-7225400000,"profit":false},{"date":"2022-12-31","value":-10645200000,"profit":false},{"date":"2023-12-31","value":-10431500000,"profit":false},{"date":"2024-12-31","value":-12972800000,"profit":false}]
Total Non-Operating Income/Expense(1.71M)130.00K23.09M15.32M14.16M[{"date":"2020-12-31","value":-7.42,"profit":false},{"date":"2021-12-31","value":0.56,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.34,"profit":true},{"date":"2024-12-31","value":61.33,"profit":true}]
Pre-Tax Income(88.29M)(72.19M)(85.98M)(96.02M)(124.70M)[{"date":"2020-12-31","value":-8829000000,"profit":false},{"date":"2021-12-31","value":-7218800000,"profit":false},{"date":"2022-12-31","value":-8598100000,"profit":false},{"date":"2023-12-31","value":-9601500000,"profit":false},{"date":"2024-12-31","value":-12469700000,"profit":false}]
Income Taxes1.83M(64.00K)(20.47M)--[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-3.5,"profit":false},{"date":"2022-12-31","value":-1119.86,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(90.12M)(72.12M)(65.51M)--[{"date":"2020-12-31","value":-9011800000,"profit":false},{"date":"2021-12-31","value":-7212400000,"profit":false},{"date":"2022-12-31","value":-6551000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(88.29M)(72.19M)(85.98M)(90.83M)(124.70M)[{"date":"2020-12-31","value":-8829000000,"profit":false},{"date":"2021-12-31","value":-7218800000,"profit":false},{"date":"2022-12-31","value":-8598100000,"profit":false},{"date":"2023-12-31","value":-9083000000,"profit":false},{"date":"2024-12-31","value":-12469700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(88.29M)(72.19M)(85.98M)(96.02M)(124.70M)[{"date":"2020-12-31","value":-8829000000,"profit":false},{"date":"2021-12-31","value":-7218800000,"profit":false},{"date":"2022-12-31","value":-8598100000,"profit":false},{"date":"2023-12-31","value":-9601500000,"profit":false},{"date":"2024-12-31","value":-12469700000,"profit":false}]
EPS (Diluted)(24.75)(10.20)(9.99)(4.80)(3.04)[{"date":"2020-12-31","value":-2475,"profit":false},{"date":"2021-12-31","value":-1020,"profit":false},{"date":"2022-12-31","value":-999,"profit":false},{"date":"2023-12-31","value":-480,"profit":false},{"date":"2024-12-31","value":-304,"profit":false}]

Solid Biosciences LLC Ratios

Solid Biosciences LLC Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SLDB
Cash Ratio 6.50
Current Ratio 6.74

Solid Biosciences LLC Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SLDB
ROA (LTM) -43.67%
ROE (LTM) -86.83%

Solid Biosciences LLC Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SLDB
Debt Ratio Lower is generally better. Negative is bad. 0.20
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.80

Solid Biosciences LLC Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SLDB
Trailing PE NM
Forward PE NM
P/S (TTM) 3.65
P/B 2.20
Price/FCF NM
EV/R 1.16
EV/Ebitda NM

FAQs

What is Solid Biosciences LLC share price today?

Solid Biosciences LLC (SLDB) share price today is $6.6

Can Indians buy Solid Biosciences LLC shares?

Yes, Indians can buy shares of Solid Biosciences LLC (SLDB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SLDB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Solid Biosciences LLC be purchased?

Yes, you can purchase fractional shares of Solid Biosciences LLC (SLDB) via the Vested app. You can start investing in Solid Biosciences LLC (SLDB) with a minimum investment of $1.

How to invest in Solid Biosciences LLC shares from India?

You can invest in shares of Solid Biosciences LLC (SLDB) via Vested in three simple steps:

  • Click on Sign Up or Invest in SLDB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Solid Biosciences LLC shares
What is Solid Biosciences LLC 52-week high and low stock price?

The 52-week high price of Solid Biosciences LLC (SLDB) is $7.37. The 52-week low price of Solid Biosciences LLC (SLDB) is $2.41.

What is Solid Biosciences LLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Solid Biosciences LLC (SLDB) is

What is Solid Biosciences LLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Solid Biosciences LLC (SLDB) is 2.20

What is Solid Biosciences LLC dividend yield?

The dividend yield of Solid Biosciences LLC (SLDB) is 0.00%

What is the Market Cap of Solid Biosciences LLC?

The market capitalization of Solid Biosciences LLC (SLDB) is $534.46M

What is Solid Biosciences LLC's stock symbol?

The stock symbol (or ticker) of Solid Biosciences LLC is SLDB

How Can Investors Use Solid Biosciences LLC Share Price Data for Long-Term Investment Decisions?

Consider the share price of Solid Biosciences LLC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Solid Biosciences LLC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Solid Biosciences LLC shares for Indian investors?

When investing in Solid Biosciences LLC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Solid Biosciences LLC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Solid Biosciences LLC share price with other stocks in the same sector?

Rather than merely checking the share price of Solid Biosciences LLC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Solid Biosciences LLC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top